Apr 30, 2026 8:30am EDT OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
Apr 30, 2026 8:00am EDT BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
Apr 28, 2026 4:05pm EDT OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
Apr 22, 2026 8:00am EDT OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
Apr 08, 2026 8:00am EDT OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
Feb 26, 2026 4:05pm EST OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Feb 04, 2026 8:00am EST OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism